BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 27, 2020
View Archived Issues
Sotira successfully completes preclinical testing of KEPTIDE COVID
Read More
Phase II experience with transmission blocking vaccine Pfs230D1M-EPA/AS01
Read More
Two first-in-human adjuvanted malaria vaccines presented
Read More
ASGR1-TLR8: an immunoTAC for the potential treatment of chronic HBV
Read More
Genfleet Therapeutics describes new RIPK1 inhibitors
Read More
TYK Medicines divulges protein kinase inhibitors
Read More
Idorsia Pharmaceuticals synthesizes new PDK1 inhibitors
Read More
Chaser Therapeutics identifies new USP28 and USP25 inhibitors
Read More
Constellation Pharmaceuticals initiates phase III MANIFEST-2 study of CPI-0610
Read More
Initial successful data presented for RLF-100 in critical COVID-19 with severe comorbidity
Read More
Abmax Biopharmaceuticals TNF-alpha-targeting antibodies
Read More
Ionis licenses second NASH candidate to AstraZeneca
Read More
Merck initiates phase II study of MK-3655 in precirrhotic NASH
Read More
Aleta presents novel CAR T-engager proteins targeting metastatic and primary CNS malignancies
Read More
Promising phase II data for MDNA-55 delivered by CED in patients with recurrent GBM
Read More
New mutations don't appear to increase SARS-CoV-2 transmissibility
Read More
Novel model of SARS-CoV-2 infection in deer mice
Read More
Faron outlines expansion plans for Clevegen development
Read More
Golden Biotechnology reports phase IIa results with antroquinonol in relapsed AML
Read More
Phase IIb data presented for GMZ2 malaria vaccine in children
Read More
Evrenzo approved in Japan for CKD anemia in adults not on dialysis
Read More
Haoma completes first-in-human study of NaQuinate for osteoporosis
Read More
E.U. approval for Symkevi with Kalydeco for children with cystic fibrosis aged 6-11 years
Read More
Petrovax partners with Intellogic to study Longidaze for pulmonary fibrosis in COVID-19 patients
Read More